Following oral arguments presented on Tuesday, the U.S. Supreme Court looked poised to rebuff a legal challenge to women's ...
A challenge to the FDA's regulation of the abortion pill mifepristone will be heard by the Supreme Court on Tuesday ...
Doubts raised whether judges and courts are better qualified than the NDA to administrate pills such as mifepristone.
Upcoming Supreme Court hearing on overturning Roe v. Wade, focusing on mifepristone access restrictions and FDA regulations.
Initiated by the Texas-based Alliance for Hippocratic Medicine against the FDA’s policies, the dispute highlights significant ...
Supreme Court justices seemed concerned about whether abortion opponents have the right to sue over mifepristone.
A majority of Supreme Court justices appeared skeptical Tuesday of the idea of a nationwide ban or new limits on mifepristone ...
the justices will weigh the future of the abortion pill mifepristone on Tuesday as they hear arguments over whether the Food and Drug Administration lawfully relaxed restrictions to make it easier ...
U.S. Supreme Court justices on Tuesday did not appear ready to limit Americans' access to the abortion pill mifepristone, in ...
The FDA indicated that the decision to separate the finalized versions of the 2016 draft guidance into discrete sections for ease of use is responsive to ... the NDI is considered to be adulterated.
Capitol Police on Tuesday morning arrested 13 protesters who were demonstrating against the Supreme Court's examination of ...
The chaos around abortion care access continues to swirl, and the latest development in a post-Roe world is no exception: ...